Copley Scientific announced that it has joined the Industries Forum of the UK’s Taskforce for Lung Health, and Copley personnel will share their expertise to help advance the taskforce’s five-year plan “to improve the nation’s lung health and provide better care for people with lung disease.” The company said, “As the world’s leading manufacturer and supplier of inhaler test equipment, Copley brings unique perspective on the safety and quality issues associated with inhaler testing and use.”
The company, which is celebrating its 75th anniversary, has recently introduced new cascade impactor software, nasal spray testing equipment, an inhaler testing work station, and an e-training service for OINDP testing.
Copley CEO Mark Copley commented, “We’re looking forward to investing in the very worthwhile work of the Taskforce for Lung Health. Lung health is currently at the forefront of people’s minds, and I hope we can help to make real progress in patient outcomes. Copley occupies a distinctive position within the inhaled product research community, and we’re pleased to be able to contribute our insight and expertise to more directly support lung disease sufferers across England.”
Read the Copley Scientific press release.
